RA Capital Nexus Fund, L.P. (CIK 1780117) reported 104 SEC Form 4 insider transactions across 7 companies over the past 18 months (most recent 2026-07-31). Recent activity: Buy ARTV (20,824 shares), Buy ARTV (24,944 shares), Buy ARTV (41,319 shares), Buy ARTV (6,522 shares), Buy ARTV (120,582 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-31 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 20,824 | $208,032 |
| 2026-07-31 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 24,944 | $247,694 |
| 2026-07-28 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 41,319 | $412,777 |
| 2026-07-23 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 6,522 | $58,307 |
| 2026-07-23 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 120,582 | $1.2M |
| 2026-07-23 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 84,124 | $835,351 |
| 2026-07-23 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 59,880 | $596,405 |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 4.9M | $49.2M |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 970,950 | $0 |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 553,703 | $0 |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 908,103 | $0 |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 367,427 | $0 |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 6.6M | $0 |
| 2026-07-22 | Freenome, Inc. (FRNM) | Director | Buy | 336,965 | $3.4M |
| 2026-07-20 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 152,472 | $1.4M |
| 2026-07-20 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 7,882 | $70,544 |
| 2026-07-14 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 15,102 | $135,465 |
| 2026-07-14 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 6,552 | $58,575 |
| 2026-06-29 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 31,000 | $275,280 |
| 2026-06-29 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 1,876 | $16,846 |
| 2026-06-16 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 391,019 | $3.4M |
| 2026-06-16 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 15,414 | $138,572 |
| 2026-06-16 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 124,893 | $1.1M |
| 2026-06-11 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 479,039 | $3.3M |
| 2026-06-11 | Artiva Biotherapeutics, Inc. (ARTV) | Director | Buy | 103 | $721 |
Source: SEC Form 4 filings · as of 2026-07-31